Stockreport

Imminent Commercial Launch of Revolutionary UST Processing Method to be Focus of Pressure BioSciences Presentation at Emerging Growth Conference 40 on September 28, 2022

PRESSURE BIOSCIENCES  (PBIO) 
US:NASDAQ Investor Relations: ir.pressurebiosciences.com
PDF Multiple Shipments of Hemp-Derived Nanoemulsified CBD Planned for Q4 2022 to Fill Existing Orders for Bulk Material Destined for White Label Use; Company Expects Q4 2022 [Read more]